Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-07-13
1992-03-10
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 530323, 530331, 530332, 548344, 562445, A61K 31195, A61K 3702, C07K 502, C07K 506
Patent
active
050950061
ABSTRACT:
Renin-inhibiting peptides of the formula ##STR1## in which X represents a group of the formula ##STR2## represents hydroxyl, alkoxy having up to 8 carbon atoms, benzyloxy or a group of the formula --NR.sup.4 R.sup.5,
REFERENCES:
patent: 4560505 (1985-12-01), Pinori et al.
patent: 4585586 (1986-04-01), Di Trapani et al.
S. H. Rosenberg et al., J. Medicinal Chemistry 30:1224-1228, 1987.
Bolis et al., J. Med. Chem. 30: 1729-1739, 1987.
Haber et al., J. Cardiovasc. Pharmac. 10(Supp. 7): S54-S58, 1987.
Plattner et al., J. Med. Chem. 31:2277-2288, 1988.
Denkewalter et al., Prog. in Drug Research 10:511-512, 1966.
A. Burger, editor, Medicinal Chemistry, 2nd Edition, pp. 565-571, 578-581, 600-601, 1960.
Bender Wolfgang
Kinast Gunther
Knorr Andreas
Stasch Johannes-Peter
Bayer Aktiengesellschaft
Walsh Stephen
Wax Robert A.
LandOfFree
Renin inhibitors having all retro-inverted peptide bonds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Renin inhibitors having all retro-inverted peptide bonds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renin inhibitors having all retro-inverted peptide bonds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2284620